The tumor‐infiltrating lymphocytes (TILs) and expression of CD8 (cytotoxic T‐cells) and CD4 (T‐helper cells) are valuable prognostic markers in breast cancer.14, 15, 16. This evidence concerns the gene CD8A and neoplasm.